The effects of thyroidectomy (Tx) and thyroxine replacement (T4Rx) on pituitary growth hormone (GH) secretion and hypothalamic GH-releasing hormone (GRH) concentration were compared to define the mechanism of hypothyroid-associated GH deficiency. Thyroidectomized rats exhibited a complete loss of pulsatile GH secretion with extensive reduction in GRH responsiveness and pituitary GH content. Cultured pituitary cells from Tx rats exhibited reduced GRH sensitivity, maximal GH responsiveness, and intracellular cyclic AMP accumulation to GRH, while somatostatin (SRIF) suppressive effects on GH secretion were increased. Hypothalamic GRH content was also markedly reduced. T4Rx completely restored hypothalamic GRH content and spontaneous GH secretion despite only partial recovery of pituitary GH content, GRH and SRIF sensitivity, and intracellular cyclic AMP response to GRH. The results indicate multiple effects of hypothyroidism on GH secretion and suggest that a critical role of T4 in maintaining normal GH secretion, in addition to restoring GH synthesis, is related to its effect on hypothalamic GRH.
Introduction
Growth hormone (GH)' secretion requires the presence of thyroid hormones, which have been shown to exert important effects on GH messenger RNA (mRNA) transcription and hormone biosynthesis (1) . Consequently, in both man and experimental animals, thyroid hormone deficiency is associated with an impairment in GH secretion that has been attributed to decreased somatotroph GH content (2) (3) (4) (5) (6) (7) . Thyroxine or triiodothyronine treatment of hypothyroid animals restores both GH secretion and pituitary GH content to normal (8, 9) .
Attention has recently been given to a possibly broader role ofthyroid hormones in the regulation ofGH secretion as further knowledge of the central nervous system (CNS) control of GH 1 . Abbreviations used in this paper: ACN, acetonitrile; GH, growth hormone; GRH, growth-releasing hormone; hGRH, human GRH; rGRH, rat GRH; SRIF, somatostatin; T4Rx, thyroxine replacement; TSH, thyrotropin; Tx, thyroidectomized. has accumulated. It is now recognized that GH secretion is modulated by stimulatory and inhibitory hypothalamic peptides: GH-releasing hormone (GRH) and somatostatin (SRIF), respectively. Previous studies from this laboratory have demonstrated significant decreases in both the hypothalamic content and release of SRIF in hypothyroid rats (10). These changes, which would not contribute to a decrease in GH secretion, are the results of either a primary consequence of thyroid hormone deficiency on somatostatinergic neurons or are secondary to the reduced secretion of GH (1 1).
The isolation and characterization of GRH (12, 13) has made possible the study ofadditional potential sites ofthyroid hormone action. Thyroid hormone deficiency has been reported to impair the GH secretory responses to GRH in rat pituitary monolayer cultures (14) and in vivo in the rat (15) and man (16) . None of these reports addressed the mechanism of this effect, however, and in all diminished pituitary GH stores could explain the re- sults.
The present study was designed to further assess the effect ofthyroid hormone deficiency and replacement on GH secretion and to study the underlying mechanisms using both in vivo and in vitro techniques. For this purpose we evaluated spontaneous and GRH-stimulated GH secretion in conscious rats and the effects of GRH and SRIF on GH release and cAMP accumulation in vitro. In addition, the effect of thyroid hormone deficiency on hypothalamic GRH content was examined by a specific radioimmunoassay.
Methods
Animals. Adult male Sprague-Dawley rats that had undergone either surgical thyroidectomy or sham operation at the age of 8 wk, were purchased from Harlan Industries Inc. (Indianapolis, IN) . The animals were housed for at least 4 wk after arrival in an environmentally controlled room (lights on: 0600-1800 h, temperature: 23±1 'C), with water and food provided ad libitum. Intravenous cannulae were then implanted into the right atrium as previously described (17) . After cannulation, animals were caged individually, handled and weighed daily by the same investigator, and adapted to specific blood sampling procedures (18).
The animals were divided into three groups 2 wk after cannulation, when body weight and behavior had returned to preoperative levels. The two groups of thyroidectomized animals were injected daily at 1700 h with saline, 0.1 ml/100 g, (Tx) or L-thyroxine, 2 AWl I00 g, (T4Rx) through the indwelling cannula for a period of 7 d. The sham-operated controls of the third group were injected with saline in a similar manner. Three separate experiments were performed at l-wk intervals using the identical protocol. The results ofeach experiment were similar and have therefore been combined. A total of 30 animals, 10 in each of the three groups, was studied.
Evaluation ofspontaneous GH secretion and GRH responsiveness in vivo. On the fifth day, blood samples (0.2 ml) were withdrawn from the intraatrial cannula at 10-20-min intervals from 1000 to 1400 h to assess the pattern of spontaneous GH secretion. All blood samples were immediately centrifuged and the plasma was separated and stored at -20°C for subsequent GH and thyrotropin (TSH) radioimmunoassay (RIA). After blood sampling, erythrocytes were resuspended in saline and returned to the same animal after collecting the subsequent blood sample. On the seventh day, the animals were injected with human GRH1-40)-OH (hGRH), 1 ug/l00 g, (kindly provided by Dr. J. Rivier, Salk Institute, San Diego, CA) at 1100 h when plasma GH concentrations were expected to be at trough levels (17) (18) (19) and the blood sampling procedure was repeated. hGRH was dissolved in acidified saline (pH 4.0) containing 1% albumin at a concentration of 10 ug/ml just prior to injection through the indwelling cannula.
Cell dissociation and in vitro incubation protocol. On the eighth day, the animals were killed by decapitation and hypothalami, anterior pituitary glands, and trunk blood were collected. The anterior pituitaries from each group of animals were enzymatically dissociated according to previously described methods (20 
Results
Effect ofthyroidectomy on spontaneous GH secretion. Thyroidectomized rats exhibited impaired weight gain as compared with controls (68±5 vs. 155±5 g) during the 37-d period ofobservation and plasma TSH levels were also markedly elevated (12,444±757 vs. 579±101 ng/ml, P < 0.001). Plasma TSH levels in thyroxine-CONTROL I HYPOTHYROID replaced (T4Rx) rats were markedly reduced (2,200±631 ng/ml) but still elevated as compared with controls (P < 0.01). During treatment T4Rx animals demonstrated significant weight gain (9.7±1.6 g) as compared with TX rats (0.03±1.4 g, P < 0.01) but only half as much as controls (17.5±2.0 g, P < 0.01). Plasma T4 levels in control, Tx, and T4Rx rats were 1.24±0.09, undetectable, and 2.42±0.33 ng/dl, respectively.
GH secretion in control animals was pulsatile, with spontaneous GH secretory bursts occurring between 1 120 and 1300 h in individual animals (Fig. 1) . In contrast, Tx animals showed a virtually complete loss ofspontaneous GH secretion. Integrated GH secretion during the 4-h period was decreased by 91% from that in control rats (P < 0.001) ( Table I) . Treatment of Tx animals with T4 for 4 d resulted in a return of spontaneous GH secretion with an integrated GH secretion statistically indistinguishable (93%) from that of controls.
Effect ofthyroidectomy on the in vivo GH secretory response to GRH. Intravenous injection ofhGRH (1 Atg/l 00 g) into control rats at 1 100 h led to a rapid increase in plasma GH levels followed by an equally rapid decline (Fig. 2) . The expected spontaneous GH secretion was either delayed or did not occur during the experimental period. Tx rats exhibited a 98% reduction (P < 0.001) in the peak secretory response and a 95% reduction in the integrated response to hGRH ( (Fig. 3) .
To normalize for the large differences in intracellular GH content among the three groups, all GH responses to GRH were expressed as a percentage ofintracellular GH content. However, analysis of the results using the absolute levels of medium GH or the percentage of GRH-stimulated increase above basal GH release also resulted in group differences that were similar in all respects.
Effect ofthyroidectomy on pituitary GH responses to GRH. Exposure of control cells to hGRH at concentrations from 0.01 nM to 13 nM resulted in a maximal 5.5-fold increase in GH release with a calculated 50% effective dose (ED50) of 0.07 nM (Fig. 3) . At the maximal stimulatory dose, 79% of intracellular GH content was released during the 4- (Fig. 4) . Greater sensitivity to the suppressive effects of SRIF were observed in cells from Tx rats with an IC 0 of 0.10 nM (P < 0.01 vs. controls). Cells from T4Rx animals were less sensitive to SRIF (IC50: 0.20 nM) than were cells from Tx animals (P < 0.01), though they continued to exhibit greater sensitivity than did controls. Effect ofthyroidectomy on hypothalamic GRH content. Immunoreactive GRH levels in the three groups are shown in Table  III . In Tx animals, hypothalamic GRH content was decreased by 50% while T4 treatment restored GRH content to levels indistinguishable from those of controls.
Discussion
The present results indicate that the effects of thyroid hormone deficiency are complex and include actions at multiple sites involved in the regulation ofGH secretion. The use ofa combined in vivo/in vitro experimental design permitted the examination of individual components of this regulatory system in the same animals and also allowed an assessment of the relative importance of each in the overall impairment of GH secretion. GH secretion in the conscious rat is pulsatile with secretory bursts occurring regularly at 3-4-h intervals (17, 27) . The effect of thyroidectomy on spontaneous GH secretion was profound in that virtually no ultradian secretory episodes were detectable and most plasma GH levels were at or beneath the limit of detection ofthe assay. The GH response to an intravenous injection of GRH was similarly affected by thyroidectomy with the reduction in the peak secretory response being virtually complete. Short-term thyroxine treatment resulted in a dissociation in the recovery of spontaneous as compared to exogenously stimulated GH secretion. After 4 Despite the marked reduction of pituitary GH content in hypothyroid animals, the percentage of stored GH that was released in vitro under basal conditions was comparable to controls. These results provided the rationale for analyzing the GH secretory response to GRH as a function of the total cell content and allowed for a meaningful comparison of the three experimental groups despite large differences in somatotroph GH stores.
The effects of GRH on somatotrophs from hypothyroid rats were quantitatively and qualitatively different from those on controls. Maximal GH release from hypothyroid somatotrophs was reduced by nearly 50%o and the ED50 was increased threefold. These alterations imply at least two different effects of thyroid hormone deficiency. The increased ED50 could be explained by a decrease in the number of somatotroph GRH receptors. Thyroid hormone has been shown to decrease pituitary TRH receptors (28, 29) and reciprocal effects on GRH receptors could explain the changes. These findings are in agreement with the report by Vale et al. (30) that the addition ofT3 in vitro decreases the ED50 of GRH for GH release in normal pituitary cells. They are at variance, however, with the results of Dieguez et al. (14) that suggested an absence of an alteration in the EDO for GRH in hypothyroid rats. Less severe hypothyroidism and variations in culture conditions would appear to explain the differences between that study and the present results. The decrease in hypothalamic GRH content observed in the present study could also result in reduced GRH delivery to the pituitary, which may contribute to changes in the somatotroph GRH receptor. The lack of deviation from parallelism of the GRH dose-response curves argues against a change in the ED"0 due to an effect of thyroid hormone deficiency on the binding affinity of the GRH receptor.
The decrease in maximal GH response, however, requires a different explanation since it has been reported that only 10-20% occupancy of GRH receptors is required for a maximal biologic response (31) . This suggests that thyroid hormone deficiency modifies the GRH-releaseable pool of somatotroph GH or leads to an impairment of a postreceptor process. Evidence for such a defect was uncovered by measurement ofintracellular cAMP levels. No differences were observed in basal cAMP levels in pituitaries from hypothyroid and control rats, though the contribution of somatotrophs, which constitutes only 30% of total pituitary cells in male rats (32) to this measurement cannot be determined from the present study. However, in response to GRH, a marked impairment of cAMP accumulation was noted in hypothyroid rats. Since cAMP is believed to mediate, at least in part, the GH-releasing effect of GRH (21, (33) (34) (35) (36) as well as its effects on GH synthesis (37-39), our results suggest that hypothyroidism leads to a defect in adenylate cyclase function or in its linkage to the GRH receptor.
Somatotrophs from thyroxine-treated rats exhibited a reduction in the ED50 for GRH, an increase in the maximal GH response, and an increase in cAMP generation as compared to hypothyroid rats. The effects of thyroxine on the ED50 and on cAMP were only partial, which is most likely explained by the limited duration of treatment. It emphasizes, however, that complete recovery of these parameters of GRH action need not occur in order to have full restoration of spontaneous GH secretion in vivo. The relatively minimal recovery of cAMP generation, in particular, is noteworthy since it implies that only a small increase in this intracellular messenger may be required for normal spontaneous GH secretion. This observation of a smaller fractional increase in cAMP generation than in GH secretion is consistent with the reported differences in the EDMm of GRH for these two parameters (21).
Another intrapituitary effect contributing to the impaired GH secretion in thyroid hormone deficiency is the enhancement of sensitivity to SRIF. Hypothyroidism is associated with decreased SRIF secretion (10) and it is tempting to speculate that this, in turn, could result in an increase in SRIF receptor density on the somatotroph (40, 41). Although Hinkle et al. (42) failed to uncover any consistent changes in SRIF receptors by in vitro addition and/or deletion of thyroid hormone to pituitary tumor cell cultures, changes occurring in response to hypothyroidism in vivo may still occur. As with GRH, thyroxine treatment only partially restored SRIF sensitivity to normal at the time of study.
The other major locus at which thyroid hormone deficiency could influence GH secretion is the hypothalamus and the present study has demonstrated a highly significant reduction in hypothalamic GRH levels in hypothyroid animals. Although the sensitivity of our assay was insufficient to quantitate release of GRH from the hypothalamus, such an effect would be expected if content and release of GRH are related as are those of SRIF (10). In contrast to the effects of thyroxine replacement on the pituitary, which were only partial, hypothalamic GRH levels were restored completely to control levels.
This study thus has demonstrated four effects ofthyroid hormone deficiency, in addition to the previously recognized decrease in GH synthesis, that contribute to the impaired secretion of GH in vivo: (a) decreased ED50 and maximal response to GRH in vitro, (b) impaired cAMP accumulation in response to GRH, (c) increased sensitivity (IC50) to SRIF, and (d) decreased hypothalamic GRH content. While the present data cannot quantitatively differentiate the relative contributions of each of these actions on the impairment of GH secretion seen in vivo, two conclusions seem warranted. First, the marked reduction of pituitary GH content observed in severe hypothyroidism overshadows the other effects and is, without question, the quantitatively most significant factor in the nearly complete absence of GH secretion. Second, complete recovery of spontaneous GH secretion occurs at a time when GH content and both the GH secretory response and the cAMP stimulatory response to GRH are still impaired, but when hypothalamic GRil content is restored to normal. This suggests that the most critical effect ofthyroid hormone in maintaining normal GH secretion occurs in the hypothalamus and is related to preservation ofthe normal secretion of GRH.
